search
Back to results

Pemoline for Cocaine Abuse - 7

Primary Purpose

Cocaine-Related Disorders

Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Pemoline
Sponsored by
Yale University
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cocaine-Related Disorders focused on measuring pemoline

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Please contact site for information.

Sites / Locations

  • VA Connecticut Healthcare System

Outcomes

Primary Outcome Measures

Side effects
Drug use
Retention

Secondary Outcome Measures

Full Information

First Posted
September 20, 1999
Last Updated
December 13, 2016
Sponsor
Yale University
Collaborators
National Institute on Drug Abuse (NIDA), VA Connecticut Healthcare System
search

1. Study Identification

Unique Protocol Identification Number
NCT00000282
Brief Title
Pemoline for Cocaine Abuse - 7
Official Title
Pemoline for Cocaine Abuse
Study Type
Interventional

2. Study Status

Record Verification Date
December 2016
Overall Recruitment Status
Completed
Study Start Date
September 1994 (undefined)
Primary Completion Date
August 1999 (Actual)
Study Completion Date
August 1999 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Yale University
Collaborators
National Institute on Drug Abuse (NIDA), VA Connecticut Healthcare System

4. Oversight

5. Study Description

Brief Summary
The purpose of this study is to evaluate the treatment of pemoline for cocaine abuse.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cocaine-Related Disorders
Keywords
pemoline

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Enrollment
0 (false)

8. Arms, Groups, and Interventions

Intervention Type
Drug
Intervention Name(s)
Pemoline
Primary Outcome Measure Information:
Title
Side effects
Title
Drug use
Title
Retention

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Please contact site for information.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Thomas R Kosten, M.D.
Organizational Affiliation
VA Connecticut Healthcare System
Official's Role
Principal Investigator
Facility Information:
Facility Name
VA Connecticut Healthcare System
City
New Haven
State/Province
Connecticut
ZIP/Postal Code
06519
Country
United States

12. IPD Sharing Statement

Citations:
Citation
J Psychoactive Drugs 28:301-304, 1996. Addictive Beh. 22, 1997. Am J Addiction 5, 275, 1996.
Results Reference
background

Learn more about this trial

Pemoline for Cocaine Abuse - 7

We'll reach out to this number within 24 hrs